{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:36:15Z","timestamp":1791045375522,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1378\/chest.10-2473","type":"journal-article","created":{"date-parts":[[2011,4,7]],"date-time":"2011-04-07T22:44:14Z","timestamp":1302216254000},"page":"1016-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease"],"prefix":"10.1016","volume":"140","author":[{"given":"David","family":"Launay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Berezne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Jean","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bletry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzedine","family":"Yaici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Le Pavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Clerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.10-2473_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12016-009-8194-2","article-title":"Scleroderma lung disease","volume":"40","author":"Le Pavec","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1378\/chest.10-2473_bib2","first-page":"1005","article-title":"Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease","volume":"34","author":"Launay","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.10-2473_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1378\/chest.10-2473_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.21538","article-title":"Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease","volume":"54","author":"Trad","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1378\/chest.10-2473_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1378\/chest.10-2473_bib6","first-page":"2398","article-title":"Scleroderma patients with combined pulmonary hypertension and interstitial lung disease","volume":"30","author":"Chang","year":"2003","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"10.1378\/chest.10-2473_bib7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 6","key":"10.1378\/chest.10-2473_bib8","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.10-0087","article-title":"Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective","volume":"137","author":"Minai","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.10-2473_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1233315","article-title":"Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases","volume":"30","author":"Weitzenblum","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.10-2473_bib10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.10-2473_bib11","first-page":"269","article-title":"Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma","volume":"33","author":"Chang","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.10-2473_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.10-2473_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.10-2473_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1378\/chest.10-2473_bib15","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"issue":"suppl 16","key":"10.1378\/chest.10-2473_bib16","first-page":"41","article-title":"Standardization of the measurements of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"issue":"3","key":"10.1378\/chest.10-2473_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/rheumatology\/kep398","article-title":"Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil","volume":"49","author":"Launay","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1378\/chest.10-2473_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1378\/chest.10-2473_bib19","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1378\/chest.10-2473_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1378\/chest.10-2473_bib21","first-page":"2230","article-title":"Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody","volume":"34","author":"Steen","year":"2007","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1378\/chest.10-2473_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/bja\/aen214","article-title":"Can intravenous endothelin-1 be used to enhance hypoxic pulmonary vasoconstriction in healthy humans?","volume":"101","author":"Talbot","year":"2008","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1378\/chest.10-2473_bib23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.10-2473_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1378\/chest.10-2473_bib25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/thx.2008.112847","article-title":"Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension","volume":"64","author":"Corte","year":"2009","journal-title":"Thorax"},{"issue":"20","key":"10.1378\/chest.10-2473_bib26","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1378\/chest.10-2473_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09031936.00081009","article-title":"Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension","volume":"35","author":"Dorfm\u00fcller","year":"2010","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1378\/chest.10-2473_bib28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfm\u00fcller","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1378\/chest.10-2473_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00106008","article-title":"Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy","volume":"34","author":"Overbeek","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.10-2473_bib30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.00102609","article-title":"Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.10-2473_bib31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1378\/chest.09-0455","article-title":"Pulmonary venoocclusive disease and failure of specific therapy","volume":"136","author":"Montani","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.10-2473_bib32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1183\/09031936.00017809","article-title":"Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.10-2473_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/eurheartj\/ehi728","article-title":"Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.10-2473_bib34","unstructured":"Le Pavec J, Girgis RE, Lechtzin N, et al. Systemic sclerosis related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum In press"},{"issue":"11","key":"10.1378\/chest.10-2473_bib35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211605394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211605394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:24:42Z","timestamp":1757917482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369211605394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0012369211605394"],"URL":"https:\/\/doi.org\/10.1378\/chest.10-2473","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.10-2473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}